Short-Chain Fatty Acids in the Human Colon: Relation to Gastrointestinal Health and Disease

1996 ◽  
Vol 31 (sup216) ◽  
pp. 132-148 ◽  
Author(s):  
P. Brøbech Mortensen ◽  
M. Rye Clausen
Gut ◽  
1981 ◽  
Vol 22 (9) ◽  
pp. 763-779 ◽  
Author(s):  
J H Cummings

2008 ◽  
Vol 56 (13) ◽  
pp. 5415-5421 ◽  
Author(s):  
Uri Lesmes ◽  
Emma J. Beards ◽  
Glenn R. Gibson ◽  
Kieran M. Tuohy ◽  
Eyal Shimoni

Microbiology ◽  
2009 ◽  
Vol 155 (11) ◽  
pp. 3554-3563 ◽  
Author(s):  
Sylvia Herold ◽  
James C. Paton ◽  
Potjanee Srimanote ◽  
Adrienne W. Paton

Shiga-toxigenic Escherichia coli (STEC) colonizing the bowel are exposed to a variety of short-chain fatty acids (SCFAs), including acetate, propionate and butyrate, produced by gut microflora. However, the total concentrations and relative amounts of SCFAs in the lumen vary with intestinal niche. Here we report that conditions simulating SCFA concentrations present in the human gut trigger expression of the iha gene, which encodes an adherence-conferring outer-membrane protein of pathogenic E. coli. We show that growth under conditions simulating colonic, but not ileal, SCFA concentrations increases iha expression in three tested STEC strains, with the strongest expression detected in LEE-negative STEC O113:H21 strain 98NK2. Expression of iha is known to be subject to Fur-mediated iron repression in O157:H7 STEC, and the same occurs in 98NK2. However, exogenous iron did not repress iha expression in the presence of colonic SCFAs in either 98NK2 or the O157:H7 strain EDL933. Moreover, exposure to the iron chelator 2,2′-dipyridyl caused no further enhancement of iha expression over that induced by colonic SCFAs. These findings indicate that SCFAs regulate iha expression in STEC independently of iron. Increased expression of iha under colonic but not ileal SCFA conditions possibly may contribute to preferential colonization of the human colon by STEC.


2014 ◽  
pp. 91-119 ◽  
Author(s):  
Jian Tan ◽  
Craig McKenzie ◽  
Maria Potamitis ◽  
Alison N. Thorburn ◽  
Charles R. Mackay ◽  
...  

2013 ◽  
Vol 25 (12) ◽  
pp. 943-949 ◽  
Author(s):  
P. Jouët ◽  
D. Moussata ◽  
H. Duboc ◽  
G. Boschetti ◽  
A. Attar ◽  
...  

ISRN Allergy ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Paul V. Licciardi ◽  
Katherine Ververis ◽  
Tom C. Karagiannis

Changes in diet can also have dramatic effects on the composition of gut microbiota. Commensal bacteria of the gastrointestinal tract are critical regulators of health and disease by protecting against pathogen encounter whilst also maintaining immune tolerance to certain allergens. Moreover, consumption of fibre and vegetables typical of a non-Western diet generates substantial quantities of short-chain fatty acids (SCFAs) which have potent anti-inflammatory properties. Dietary interventions such as probiotic supplementation have been investigated for their pleiotropic effects on microbiota composition and immune function. Probiotics may restore intestinal dysbiosis and improve clinical disease through elevated SCFA levels in the intestine. Although the precise mechanisms by which such dietary factors mediate these effects, SCFA metabolites such as butyrate also function as histone deacetylase inhibitors (HDACi), that can act on the epigenome through chromatin remodeling changes. The aim of this review is to provide an overview of HDAC enzymes and to discuss the biological effects of HDACi. Further, we discuss the important relationship between diet and the balance between health and disease and how novel dietary interventions such as probiotics could be alternative approach for the prevention and/or treatment of chronic inflammatory disease through modulation of the intestinal microbiome.


Redox Biology ◽  
2021 ◽  
pp. 102165
Author(s):  
Carmen González-Bosch ◽  
Emily Boorman ◽  
Patricia A. Zunszain ◽  
Giovanni E. Mann

Sign in / Sign up

Export Citation Format

Share Document